13F Filings History of Clean Yield Group

Latest 13F report
Q3 2025 - 23 Oct 2025
Value $
$353,802,170
Signature - Title
Jenny Ly - Operations and Reconciliation Manager
Location
Norwich, VT
Summary
This page shows a list of all the recent 13F filings made by Clean Yield Group. Form 13F is required to be filed within 45 days of the end of a calendar quarter. Clean Yield Group reported 416 stock holdings with total value $353,802,170 as of Q3 2025. Top holdings included AAPL, NVDA, AVGO, AWK, and ASML.

Notify me when Clean Yield Group files a new 13F portfolio report.

⭐ Subscribe ⭐
Holdings Value
Quarter Holdings Value $ Bought Sold Net Top Holdings Form Type Filing Time
Q3 2025 416 $353,802,170 +$11,277,698 -$6,528,514 +$4,749,184 AAPL, NVDA, AVGO, AWK, ASML 13F-HR 23 Oct 2025, 11:37
Q2 2025 399 $334,292,426 +$21,233,288 -$15,355,927 +$5,877,361 AAPL, NVDA, AVGO, SFM, AWK 13F-HR 17 Jul 2025, 12:16
Q1 2025 444 $306,929,823 +$20,015,351 -$19,956,859 +$58,492 AAPL, SFM, NVDA, AWK, UL 13F-HR 14 Apr 2025, 09:41
Q4 2024 454 $314,392,028 +$27,607,968 -$15,811,517 +$11,796,451 AAPL, SFM, NVDA, AVGO, UL 13F-HR 13 Jan 2025, 14:24
Q3 2024 469 $314,573,669 +$43,466,662 -$26,585,097 +$16,881,565 AAPL, SFM, UL, NVDA, AWK 13F-HR 07 Oct 2024, 11:33
Q2 2024 362 $267,708,058 +$18,600,108 -$11,983,221 +$6,616,887 AAPL, SFM, UL, GSK, AWK 13F-HR 10 Jul 2024, 10:57
Q1 2024 379 $257,055,940 +$24,257,282 -$12,901,592 +$11,355,690 AAPL, GSK, UL, SFM, DOC 13F-HR 29 May 2024, 11:39
Q4 2023 363 $237,411,234 +$6,016,244 -$9,976,604 -$3,960,360 AAPL, UL, GSK, TAK, SFM 13F-HR 24 Jan 2024, 15:15
Q3 2023 371 $221,767,731 +$9,323,362 -$7,836,869 +$1,486,493 AAPL, UL, TAK, GSK, VOD 13F-HR 12 Oct 2023, 14:00
Q2 2023 401 $242,782,830 +$15,472,183 -$7,226,500 +$8,245,683 AAPL, UL, TAK, GSK, VOD 13F-HR 26 Jul 2023, 10:11
Q1 2023 420 $234,753,227 +$11,550,708 -$10,654,983 +$895,725 AAPL, UL, TAK, GSK, DOC 13F-HR 26 Apr 2023, 09:50
Q4 2022 452 $232,814,271 +$15,968,906 -$15,505,292 +$463,614 AAPL, UL, TAK, GSK, DOC 13F-HR 31 Jan 2023, 14:10
Q3 2022 426 $215,439,000 +$20,614,042 -$13,824,561 +$6,789,481 AAPL, UL, VOD, TAK, DOC 13F-HR 31 Oct 2022, 11:49
Q2 2022 410 $241,922,000 +$15,330,922 -$22,944,896 -$7,613,974 AAPL, GSKXXXX, UL, VOD, DOC 13F-HR 18 Jul 2022, 15:47
Q1 2022 458 $283,134,000 +$18,297,754 -$30,452,913 -$12,155,159 AAPL, GSKXXXX, GRNB, UL, TU 13F-HR 25 Apr 2022, 15:49
Q4 2021 441 $312,811,078 +$10,580,689 -$21,596,836 -$11,016,147 AAPL, GRNB, GSKXXXX, TU, UL 13F-HR 24 Jan 2022, 14:58
Q3 2021 467 $282,500,000 +$22,439,001 -$7,176,249 +$15,262,752 AAPL, GRNB, CNBKA, GSKXXXX, UL 13F-HR 27 Oct 2021, 14:18
Q2 2021 454 $269,371,000 +$28,198,270 -$15,127,344 +$13,070,926 AAPL, GRNB, CNBKA, GSKXXXX, UL 13F-HR 26 Jul 2021, 16:24
Q1 2021 147 $242,060,000 +$21,763,137 -$27,495,658 -$5,732,521 AAPL, CNBKA, VOD, VMBS, UL 13F-HR 26 Apr 2021, 14:10
Q4 2020 418 $278,204,000 +$35,147,608 -$21,101,569 +$14,046,039 AAPL, HASI, UL, TU, CNBKA 13F-HR 26 Jan 2021, 10:04
Q3 2020 362 $246,621,000 +$16,995,679 -$7,123,171 +$9,872,508 AAPL, UN, HASI, VOD, TU 13F-HR 16 Oct 2020, 10:41
Q2 2020 332 $231,388,000 +$10,205,910 -$24,285,613 -$14,079,703 AAPL, CNBKA, UN, VOD, TU 13F-HR 22 Jul 2020, 14:40
Q1 2020 370 $210,502,012 +$18,511,037 -$59,542,634 -$41,031,597 CNBKA, AAPL, UN, VOD, TU 13F-HR 20 Apr 2020, 13:49
Q4 2019 342 $318,865,153 +$16,017,024 -$13,317,439 +$2,699,585 CNBKA, AAPL, JNJ, UN, VOD 13F-HR 17 Jan 2020, 11:46
Q3 2019 334 $302,924,260 +$33,484,248 -$11,479,138 +$22,005,110 CNBKA, JNJ, AAPL, VOD, GIS 13F-HR 23 Oct 2019, 15:25
Q2 2019 328 $276,644,000 +$44,723,583 -$17,646,225 +$27,077,358 CNBKA, JNJ, AAPL, XRAY, GIS 13F-HR 22 Jul 2019, 14:46
Q1 2019 307 $246,688,282 +$15,722,470 -$25,913,855 -$10,191,385 CNBKA, JNJ, AAPL, VOD, GIS 13F-HR 24 Apr 2019, 15:16
Q4 2018 295 $229,680,000 +$18,778,523 -$12,238,672 +$6,539,851 AAPL, CNBKA, JNJ, CSCO, CXP 13F-HR 23 Jan 2019, 10:44
Q3 2018 137 $251,246,000 +$17,110,685 -$14,461,779 +$2,648,906 AAPL, CSCO, JNJ, CNBKA, CXP 13F-HR 22 Oct 2018, 15:53
Q2 2018 132 $241,438,000 +$12,429,965 -$9,904,401 +$2,525,564 AAPL, CSCO, CNBKA, CXP, JNJ 13F-HR 24 Jul 2018, 13:38
Q1 2018 131 $236,808,000 +$16,376,777 -$19,403,786 -$3,027,009 AAPL, CSCO, CNBKA, JNJ, CXP 13F-HR 23 Apr 2018, 11:12
Q4 2017 130 $252,605,000 +$10,126,515 -$10,217,444 -$90,929 AAPL, CSCO, JNJ, CNBKA, CXP 13F-HR 16 Jan 2018, 13:03
Q3 2017 133 $245,149,000 +$9,767,063 -$10,787,687 -$1,020,624 AAPL, CNBKA, JNJ, CSCO, ADP 13F-HR 11 Oct 2017, 11:04
Q2 2017 130 $239,047,000 +$13,853,237 -$10,343,381 +$3,509,856 AAPL, JNJ, CNBKA, CSCO, ADP 13F-HR 17 Jul 2017, 14:33
Q1 2017 294 $237,344,000 +$26,396,496 -$13,861,748 +$12,534,748 AAPL, JNJ, CSCO, CNBKA, ADP 13F-HR 03 May 2017, 14:39
Q4 2016 125 $221,714,000 +$5,569,826 -$8,017,864 -$2,448,038 AAPL, CSCO, JNJ, CNBKA, ADP 13F-HR 24 Jan 2017, 11:20
Q3 2016 312 $229,975,038 +$13,104,911 -$6,968,054 +$6,136,857 AAPL, CSCO, JNJ, VTR, MKC 13F-HR 28 Oct 2016, 13:23
Q2 2016 293 $232,918,000 +$8,301,731 -$9,035,136 -$733,405 AAPL, JNJ, CSCO, MKC, VTR 13F-HR 27 Jul 2016, 11:38
Q1 2016 287 $224,903,000 +$16,367,571 -$13,999,612 +$2,367,959 AAPL, CSCO, JNJ, MKC, GAS 13F-HR 15 Apr 2016, 10:57
Q4 2015 122 $200,424,000 +$18,117,834 -$6,302,827 +$11,815,007 AAPL, GAS, JNJ, MKC, CSCO 13F-HR 27 Jan 2016, 09:39
Q3 2015 121 $209,069,000 +$20,098,248 -$15,835,253 +$4,262,995 AAPL, GAS, CSCO, MKC, JNJ 13F-HR 29 Oct 2015, 12:07
Q2 2015 127 $217,666,000 +$15,704,875 -$15,304,816 +$400,059 AAPL, MKC, JNJ, CSCO, EMR 13F-HR 31 Jul 2015, 14:00
Q1 2015 352 $233,254,000 +$26,968,450 -$15,609,526 +$11,358,924 AAPL, JNJ, MKC, EMR, WLY 13F-HR 24 Apr 2015, 12:11
Q4 2014 126 $222,754,000 +$11,559,588 -$5,035,297 +$6,524,291 AAPL, DD, JNJ, GAS, MKC 13F-HR 29 Jan 2015, 11:02
Q3 2014 122 $208,214,000 +$16,160,153 -$5,869,466 +$10,290,687 AAPL, JNJ, DD, GAS, ADP 13F-HR 27 Oct 2014, 11:56
Q2 2014 126 $202,409,000 +$18,001,693 -$6,232,910 +$11,768,783 AAPL, JNJ, GAS, WLY, MKC 13F-HR 21 Jul 2014, 14:23
Q1 2014 115 $193,376,000 +$19,999,542 -$9,860,811 +$10,138,731 AAPL, JNJ, MKC, WLY, GAS 13F-HR 24 Apr 2014, 14:56
Q4 2013 112 $186,840,000 $0 AAPL, DD, MKC, WLY, ADP 13F-HR 31 Jan 2014, 09:38